Craft

Indaptus Therapeutics

Stock Price

$1.2

2024-10-29

Market Capitalization

$12.6 M

2024-10-29

Indaptus Therapeutics Summary

Company Summary

Overview
Indaptus Therapeutics. is a biopharmaceutical company that specializes in cancer and other infectious disease treatment solutions. It develops immunotherapies that treat bacteria's ability to activate both innate and adaptive cellular immune pathways and cure disease.
Type
Public
Status
Active
Founded
2021
Website
https://indaptusrx.com/
Cybersecurity rating
Sectors

Table of Contents

Footer menu